Podcast
Questions and Answers
According to the START/STOPP criteria, when should mirabegron not be used?
According to the START/STOPP criteria, when should mirabegron not be used?
- With heart failure
- Severe hypertension (correct)
- History of venous thromboembolism
- Diabetes mellitus with frequent hypoglycaemic
According to the START/STOPP criteria, which type of incontinence can Duloxetine be used for?
According to the START/STOPP criteria, which type of incontinence can Duloxetine be used for?
- Stress incontinence (correct)
- Urinary urgency
- Urge incontinence
- All of the above
Which of the following medications should not be used in patients with heart failure?
Which of the following medications should not be used in patients with heart failure?
- Mineralocorticoid receptor antagonis
- ACE inhibitors
- Thiazolidenediones (correct)
- Beta-blockers
When are beta blockers NOT indicated? (According to the START/STOPP criteria)
When are beta blockers NOT indicated? (According to the START/STOPP criteria)
According to the START/STOPP criteria, what class should SSRIs not be combined with in a patient with a previous history of major haemorrhage?
According to the START/STOPP criteria, what class should SSRIs not be combined with in a patient with a previous history of major haemorrhage?
Which drug class does NOT increase the risk for thrombosis?
Which drug class does NOT increase the risk for thrombosis?
Which antiplatelet agent is not recommended for use in any circumstances?
Which antiplatelet agent is not recommended for use in any circumstances?
What is the maximum time a patient should be on vitamin K antagonist, direct thrombin inhibitor or factor Xa inhibitors be used after first pulmonary embolus without continuing provoking risk factors?
What is the maximum time a patient should be on vitamin K antagonist, direct thrombin inhibitor or factor Xa inhibitors be used after first pulmonary embolus without continuing provoking risk factors?
T/F: Vitamin K antagonists should be the first-line anticoagulant for atrial fibrillation in all patients
T/F: Vitamin K antagonists should be the first-line anticoagulant for atrial fibrillation in all patients